Literature DB >> 17468685

The assessment of spirituality and religiousness in schizophrenia.

Sylvia Mohr1, Christiane Gillieron, Laurence Borras, Pierre-Yves Brandt, Philippe Huguelet.   

Abstract

To assess religious coping in schizophrenia, we developed and tested a clinical grid, as no validated questionnaire exists for this population. One hundred fifteen outpatients were interviewed. Results obtained by 2 clinicians were compared. Religion was central in the lives of 45% of patients, 60% used religion extensively to cope with their illness. Religion is a multifaceted construct. Principal component analysis elicited 4 factors: subjective dimension, collective dimension, synergy with psychiatric treatment, and ease of talking about religion with psychiatrist. Different associations were found between these factors and psychopathology, substance abuse, and psychosocial adaptation. The high prevalence of spirituality and religious coping clearly indicates the necessity of addressing spirituality in patient care. Our clinical grid is suitable for this purpose. It proved its applicability to a broad diversity of religious beliefs, even pathological ones. Interjudge reliability and construct validity were high and specific training is not required.

Entities:  

Mesh:

Year:  2007        PMID: 17468685     DOI: 10.1097/01.nmd.0000258230.94304.6b

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  16 in total

1.  Spirituality, schizophrenia, and state hospitals: program description and characteristics of self-selected attendees of a spirituality therapeutic group.

Authors:  Nadine Revheim; William M Greenberg; Leslie Citrome
Journal:  Psychiatr Q       Date:  2010-12

Review 2.  Instruments measuring spirituality in clinical research: a systematic review.

Authors:  Stéfanie Monod; Mark Brennan; Etienne Rochat; Estelle Martin; Stéphane Rochat; Christophe J Büla
Journal:  J Gen Intern Med       Date:  2011-07-02       Impact factor: 5.128

3.  Religious beliefs in schizophrenia: their relevance for adherence to treatment.

Authors:  L Borras; S Mohr; P-Y Brandt; C Gilliéron; A Eytan; P Huguelet
Journal:  Schizophr Bull       Date:  2007-01-09       Impact factor: 9.306

4.  Self-Transformation at the Boundary of Religious Conversion and Psychosis.

Authors:  Szabolcs Kéri
Journal:  J Relig Health       Date:  2020-02

5.  Religion and spirituality: how clinicians in quebec and geneva cope with the issue when faced with patients suffering from chronic psychosis.

Authors:  Laurence Borras; Sylvia Mohr; Christiane Gillieron; Pierre-Yves Brandt; Isabelle Rieben; Claude Leclerc; Philippe Huguelet
Journal:  Community Ment Health J       Date:  2009-09-22

6.  Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis.

Authors:  Celine Wong; Larry Davidson; Deirdre Anglin; Bruce Link; Ruth Gerson; Dolores Malaspina; Thomas McGlashan; Cheryl Corcoran
Journal:  Early Interv Psychiatry       Date:  2009-05       Impact factor: 2.732

7.  Religion's effect on mental health in schizophrenia: examining the roles of meaning-making and seeking social support.

Authors:  Naomi T Tabak; Amy Weisman de Mamani
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-07

8.  The effect of a culturally informed therapy on self-conscious emotions and burden in caregivers of patients with schizophrenia: A randomized clinical trial.

Authors:  Amy Weisman de Mamani; Giulia Suro
Journal:  Psychotherapy (Chic)       Date:  2015-12-14

9.  History of religious delusions and psychosocial functioning among Mexican patients with paranoid schizophrenia.

Authors:  Rebeca Robles-García; Sonia López-Luna; Francisco Páez; Raúl Escamilla; Beatriz Camarena; Ana Fresán
Journal:  J Relig Health       Date:  2014-12

10.  Evolution of spirituality and religiousness in chronic schizophrenia or schizo-affective disorders: a 3-years follow-up study.

Authors:  Sylvia Mohr; Laurence Borras; Isabelle Rieben; Carine Betrisey; Christiane Gillieron; Pierre-Yves Brandt; Nader Perroud; Philippe Huguelet
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-10-11       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.